Active and passive immunization protects against lethal, extreme drug resistant-Acinetobacter baumannii infection
about
Acinetobacter baumannii: evolution of antimicrobial resistance-treatment optionsImmunization against multidrug-resistant Acinetobacter baumannii effectively protects mice in both pneumonia and sepsis modelsBiology of Acinetobacter baumannii: Pathogenesis, Antibiotic Resistance Mechanisms, and Prospective Treatment OptionsChlorine dioxide is a size-selective antimicrobial agentSelectable Markers for Use in Genetic Manipulation of Extensively Drug-Resistant (XDR) Acinetobacter baumannii HUMC1.Induction of human plasmablasts during infection with antibiotic-resistant nosocomial bacteria.Transferrin iron starvation therapy for lethal bacterial and fungal infections.Immunization with lipopolysaccharide-deficient whole cells provides protective immunity in an experimental mouse model of Acinetobacter baumannii infection.Identification of novel vaccine candidates against multidrug-resistant Acinetobacter baumannii.Host fate is rapidly determined by innate effector-microbial interactions during Acinetobacter baumannii bacteremiaCryopreservation of virulent Acinetobacter baumannii to reduce variability of in vivo studies.Identification of novel vaccine candidates against Acinetobacter baumannii using reverse vaccinologyMolecular characterization and antimicrobial susceptibility of Acinetobacter baumannii isolates obtained from two hospital outbreaks in Los Angeles County, California, USAPangenome and immuno-proteomics analysis of Acinetobacter baumannii strains revealed the core peptide vaccine targets.Current advances and challenges in the development of Acinetobacter vaccines.Evaluation of the trimeric autotransporter Ata as a vaccine candidate against Acinetobacter baumannii infections.Inhibition of LpxC protects mice from resistant Acinetobacter baumannii by modulating inflammation and enhancing phagocytosisImmunization with a 22-kDa outer membrane protein elicits protective immunity to multidrug-resistant Acinetobacter baumannii.Acinetobacter baumannii rOmpA vaccine dose alters immune polarization and immunodominant epitopes.Immunoprotective Efficacy of Acinetobacter baumannii Outer Membrane Protein, FilF, Predicted In silico as a Potential Vaccine CandidateThe K1 capsular polysaccharide from Acinetobacter baumannii is a potential therapeutic target via passive immunization.Employing Escherichia coli-derived outer membrane vesicles as an antigen delivery platform elicits protective immunity against Acinetobacter baumannii infection.Antibiotic Resistance Determinant-Focused Acinetobacter baumannii Vaccine Designed Using Reverse Vaccinology.Global Gene Expression Profile of Acinetobacter baumannii During Bacteremia.Clinical and Pathophysiological Overview of Acinetobacter Infections: a Century of Challenges.The Immune Response against Acinetobacter baumannii, an Emerging Pathogen in Nosocomial Infections.Diabetes Exacerbates Infection via Hyperinflammation by Signaling through TLR4 and RAGE.Small protein A and phospholipase D immunization serves a protective role in a mouse pneumonia model of Acinetobacter baumannii infection.Human Salivary Protein Histatin 5 Has Potent Bactericidal Activity against ESKAPE Pathogens.On the path to untreatable infections: colistin use in agriculture and the end of 'last resort' antibiotics.Nanoparticles for Control of Biofilms of Acinetobacter Species.Immunoprotective potential of BamA, the outer membrane protein assembly factor, against MDR Acinetobacter baumanniiDiabetic murine models for Acinetobacter baumannii infection.Monoclonal Antibody Protects Against Acinetobacter baumannii Infection by Enhancing Bacterial Clearance and Evading Sepsis.The Capsular Polysaccharide of Acinetobacter baumannii Is an Obstacle for Therapeutic Passive Immunization Strategies.The Hyr1 protein from the fungus Candida albicans is a cross kingdom immunotherapeutic target for Acinetobacter bacterial infection.Acinetobacter spp. porin Omp33-36: Classification and transcriptional response to carbapenems and host cells
P2860
Q27015109-DFBFEFF0-D5D3-43BE-B17A-1D5879386EC5Q28539933-43E21874-FE02-4C71-B212-6AD5715DFEFCQ30235064-0C5F78B1-7169-4D27-99E1-6B35F83CCCDDQ31143715-57F4B278-6C74-452B-AFE1-1CEB0F90FF81Q33649288-720E2B42-7848-4751-A675-15A949DFA741Q33746032-19F3FC17-5A85-4D97-8256-6F8934033E01Q33883214-37CE2264-B212-4E8E-9516-4B8BED018E36Q34653632-D99BCD7B-1B03-4147-89B9-31D33DDFEB4AQ35015181-7ABCBFB3-3923-4A33-A069-891E3100D6E0Q35661920-8FF2073A-1D13-4966-B673-11300A3265B7Q35829780-30B9747B-44B6-4AB7-A67A-24379FF7BBBDQ35887251-EF3EB3BB-710F-492A-AB98-01324DA66AF7Q36008636-53C46155-A12D-4D80-8338-73B26B3222B5Q36135237-480B6931-C1E2-4728-AA62-7B234D20BC9CQ36256352-7B5A67B3-59BB-4A56-91B7-1EB3F33C62D9Q36277390-16A42F16-B77E-470F-BD97-F1C8DCE622F4Q36457770-9C92D8D7-DA4E-44EA-9CE2-DAABDC15D6A8Q36555685-6049D68F-D25B-4015-9248-EF7182BBB9E4Q36569183-5E132CCD-835B-4FC0-B590-0B40671D898FQ36573679-32078F38-FD74-429C-B083-BB4A612D2DE1Q36646787-984870B8-0422-4D67-A726-AB9317EC2EF3Q37416593-90FB57A9-BD37-41B3-ABA5-3E639E8A1F12Q37691079-DD7CC66C-6E0A-4831-8A0C-8BC1555ED90FQ38735255-4DF6F692-7CA6-4834-8BA2-E6F33DEFA917Q39038590-F8D28439-F3EF-43EA-A91B-D6F9ABFDA376Q39265442-4961E34E-DAA2-4423-9C77-3F6205F23F67Q40083827-FB9D47BD-3B60-42CD-81C2-0AC292F52195Q40183459-321F6D5F-78B1-474D-95CD-7B50ECE1C7ECQ40307588-23B9FB02-43F7-45F0-A388-67EB7B4417E4Q40600987-1CC29A87-27F7-4170-BF1A-530D89AEA7C0Q40674700-913888D4-2C1D-4508-AFDC-B6837048ED7CQ42367786-3AAF82D3-89EA-4818-A306-FCDE0AF59E6DQ43237805-042640C3-BECD-4896-A6F3-198D1EDAA38CQ43563522-B24DE1E7-5398-42D1-A9D8-F1923FF7C5ECQ47744180-BED7411E-CC04-4403-9B93-51B4F4D4D11EQ54215616-24D504B4-EBF0-4C95-80DF-7FA421678AA9Q58803761-13849CE4-19A0-481D-BFCF-0B120A6978E5
P2860
Active and passive immunization protects against lethal, extreme drug resistant-Acinetobacter baumannii infection
description
2012 nî lūn-bûn
@nan
2012 թուականին հրատարակուած գիտական յօդուած
@hyw
2012 թվականին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Active and passive immunizatio ...... netobacter baumannii infection
@ast
Active and passive immunizatio ...... netobacter baumannii infection
@en
Active and passive immunizatio ...... netobacter baumannii infection
@nl
type
label
Active and passive immunizatio ...... netobacter baumannii infection
@ast
Active and passive immunizatio ...... netobacter baumannii infection
@en
Active and passive immunizatio ...... netobacter baumannii infection
@nl
prefLabel
Active and passive immunizatio ...... netobacter baumannii infection
@ast
Active and passive immunizatio ...... netobacter baumannii infection
@en
Active and passive immunizatio ...... netobacter baumannii infection
@nl
P2093
P2860
P3181
P1433
P1476
Active and passive immunizatio ...... netobacter baumannii infection
@en
P2093
Ashraf S Ibrahim
Beverlie Baquir
Brad Spellberg
Guanpingshen Luo
Mark D Adams
Paul Pantapalangkoor
Thomas A Russo
P2860
P304
P3181
P356
10.1371/JOURNAL.PONE.0029446
P407
P577
2012-01-01T00:00:00Z